Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer’s Disease: Synthesis of Evidence from Observational and Interventional TrialsSusan Abushakra, Martin Tolar, Frederik Barkhof et al.|CNS Drugs|2025Cited by 2
Safety and ARIA Results of the Oral Anti‐Amyloid Agent Valiltramiprosate from the Phase 3 APOLLOE4 Trial in APOE4/4 Homozygotes with Early ADPatrick Kesslak, Martin Tolar, Susan Abushakra et al.|Alzheimer s & Dementia|2025Cited by 0